Your session is about to expire
← Back to Search
Candin treatment for Common Warts
Study Summary
This trial aims to see if the treatment with Candin is more effective in clearing common warts compared to a placebo. Participants will receive injections every two weeks until the wart is cleared and will be followed
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What is the current number of individuals involved in this medical study?
"Indeed, as per clinicaltrials.gov, this medical investigation is actively seeking volunteers. The trial was uploaded on March 5th, 2024 and most recently revised on March 15th, 2024. Enrollment of approximately 330 participants will be carried out across 18 diverse sites."
What is the overall safety profile of Candin therapy for individuals undergoing treatment?
"Based on our evaluation, the safety rating for Candin therapy is graded as 3 due to it being a Phase 3 trial. This signifies existing efficacy data along with extensive safety data from multiple evaluations."
Are participants currently being enrolled in this trial?
"As per clinicaltrials.gov, this investigation is actively pursuing potential candidates. It was initially shared on March 5th, 2024 and recently revised on March 15th of the same year."
How numerous are the locations conducting this investigation within our city?
"As of now, patient recruitment is ongoing at 18 different sites. These sites are situated in Bryant, Brighton, Fort Smith, and various other locations. It is advisable to choose a site nearest to you to reduce travel requirements during your potential participation."
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger